z-logo
open-access-imgOpen Access
The CYP2B6 G516T polymorphism influences CD4 + T-cell counts in HIV-positive patients receiving antiretroviral therapy in an ethnically diverse region of the Amazon
Author(s) -
Maria Alice Freitas Queiroz,
Rogério Valois Laurentino,
Ednelza da Silva Graça Amoras,
Mauro Sérgio Moura de Araújo,
Samara Tatielle Monteiro Gomes,
Sandra Souza Lima,
Antônio Carlos Rosário Vallinoto,
Marluísa de Oliveira Guimarães Ishak,
Ricardo Ishak,
Luiz Fernando Almeida Machado
Publication year - 2016
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2016.12.002
Subject(s) - efavirenz , genotype , genotyping , indinavir , creatinine , slco1b1 , immunology , biology , medicine , viral load , tenofovir , cyp2b6 , gastroenterology , antiretroviral therapy , human immunodeficiency virus (hiv) , single nucleotide polymorphism , genetics , cytochrome p450 , metabolism , cyp3a4 , gene
Cytochrome P450 (CYP) enzyme polymorphisms seem to significantly influence the variability of the responses to certain antiretroviral drugs and their toxicity levels. The objective of this study was to evaluate the influence of the CYP2B6 G516T polymorphism on hepatic, renal, immunological, and viral marker changes in HIV-1-positive patients receiving treatment in an ethnically diverse region of the Amazon.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom